Blue Water Acquisition Corp. III (BLUW)

NASDAQ: BLUW · Real-Time Price · USD
10.00
-0.01 (-0.05%)
Jun 27, 2025, 11:53 AM - Market open
Market Cap 281.20M
Revenue (ttm) n/a
Net Income (ttm) -291,246
Shares Out 28.12M
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,224
Open 10.01
Previous Close 10.01
Day's Range 10.00 - 10.01
52-Week Range 10.00 - 10.03
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About BLUW

Blue Water Acquisition Corp. III focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses in the biotechnology, healthcare and technology sectors. The company was incorporated in 2024 and is based in Greenwich, Connecticut. [Read more]

Industry Shell Companies
Sector Financials
IPO Date Jun 10, 2025
Country United States
Stock Exchange NASDAQ
Ticker Symbol BLUW
Full Company Profile

Financial Performance

Financial Statements

News

Blue Water Acquisition Corp. III Announces Closing of Upsized $253 Million Initial Public Offering

GREENWICH, Conn. , June 11, 2025 /PRNewswire/ -- Blue Water Acquisition Corp. III (the "Company") (Nasdaq: BLUWU), a newly organized special purpose acquisition company formed as a Cayman Islands exem...

16 days ago - PRNewsWire

Blue Water Acquisition Corp. III Announces the Upsized Pricing of $220 Million Initial Public Offering

GREENWICH, Conn. , June 10, 2025 /PRNewswire/ -- Blue Water Acquisition Corp. III (the "Company"), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company and...

17 days ago - PRNewsWire

U.S. IPO Weekly Recap: IPO Calendar Slows Down With Small Listings

The calendar slowed down this past week, with only small listings in the US. There was one sizable filing this past week - AIRO Group Holdings. No IPOs are currently scheduled to list in the week ahea...

4 months ago - Seeking Alpha

Healthcare SPAC Blue Water Acquisition III files for a $200 million IPO

Blue Water Acquisition III, the third blank check company led by the founder of Blue Water Venture Partners targeting healthcare, filed on Thursday with the SEC to raise up to $200 million in an initi...

4 months ago - Renaissance Capital

Blue Water Acquisition III IPO Registration Document (S-1)

Blue Water Acquisition III has filed to go public with an IPO on the NASDAQ

4 months ago - SEC

Clarus Therapeutics Closes Transaction With Blue Water, Debuts as a Publicly Traded Company to Develop Androgen and Metabolic Therapies

Business combination with Blue Water Acquisition Corp., a special purpose acquisition company, completed on September 9, 2021

4 years ago - GlobeNewsWire

Blue Water Acquisition Corp. Announces Stockholder Approval of Business Combination with Clarus Therapeutics, Inc.

GREENWICH, Conn., Aug. 27, 2021 (GLOBE NEWSWIRE) -- Blue Water Acquisition Corp. (Nasdaq: BLUW), a special purpose acquisition company (“Blue Water”), today announced that its stockholders have voted ...

4 years ago - GlobeNewsWire

A handful of heavily shorted SPACs are being squeezed higher as investors redeem shares ahead of final merger

Most SPACs have redemption rights, which give shareholders the right to sell their shares back to the acquisition company for $10 per share.

4 years ago - Business Insider

Blue Water Acquisition Corp. Announces Change of Special Meeting of Shareholders Date to August 27, 2021

NEW YORK, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Blue Water Acquisition Corp. (NASDAQ: BLUW) (“Blue Water” or the "Company"), a special purpose acquisition company (SPAC) that previously announced a planne...

4 years ago - GlobeNewsWire

Blue Water Acquisition Corp. Announces Date for Special Meeting of Stockholders to Vote on Transaction With Clarus Therapeutics, Inc.

GREENWICH, Conn., July 30, 2021 /PRNewswire/ --  Blue Water Acquisition Corp. (Nasdaq: BLUW) ("Blue Water"), a special purpose acquisition company ("SPAC") led by Joseph Hernandez, today announced tha...

4 years ago - PRNewsWire

Clarus Therapeutics And HavaH Therapeutics Announce Licensing Agreement For Product To Treat Androgen-Dependent Inflammatory Breast Disease And Certain Forms Of Breast Cancer

NORTHBROOK, Ill. and NORTH ADELAIDE, South Australia, May 25, 2021 /PRNewswire/ -- Clarus Therapeutics Inc. ("Clarus"), a pharmaceutical company dedicated to providing solutions to unmet medical needs...

4 years ago - PRNewsWire

Blue Water Acquisition Corp. Receives Expected Notice from Nasdaq Regarding Delayed Annual Report

New York, NY, April 22, 2021 (GLOBE NEWSWIRE) -- Blue Water Acquisition Corp. (NASDAQ: BLUWU) (the “Company”) announced today that it received a notice (“Notice”) from the Listing Qualifications Depar...

4 years ago - GlobeNewsWire

Blue Water Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing February 9, 2021

Greenwich, Conn., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Blue Water Acquisition Corp. (the “Company”) announced that, commencing February 9, 2021, holders of the units sold in the Company's initial public ...

4 years ago - GlobeNewsWire

Blue Water Acquisition Corporation Announces Closing of $57.5 Million Initial Public Offering, Including Full Exercise of the Underwriter's Over-Allotment Option

GREENWICH, Conn., Dec. 17, 2020 /PRNewswire/ -- Blue Water Acquisition Corporation (NASDAQ: BLUWU) (the "Company"), a special purpose acquisition company, announced today that it closed its initial pu...

4 years ago - PRNewsWire